Myrcene (beta-myrcene) is often one of the most abundant terpenes in cannabis, and it gives an earthy, musky, herbal note. It is also found in hops, lemongrass and bay leaf. Menus and budtenders often say myrcene-heavy cannabis is sedating or causes “couch lock.” That claim is widely repeated, but the evidence behind it is thin.

A 2002 mouse study found sedation and muscle relaxation from myrcene, but only at large injected doses (100 to 200 mg per kg of body weight). Lab studies in 2019 and 2020 found myrcene did not act on CB1 or CB2 receptors or change THC’s activity. We found no controlled human trial showing that myrcene in cannabis causes sleepiness. The “mango before smoking” tip has no published human study behind it.
Where the Sedation Claim Comes From
The study most often cited is a 2002 paper in Phytomedicine that tested myrcene, citral and limonene in mice. Myrcene reduced movement and caused muscle relaxation, and at the highest dose it extended barbiturate-induced sleep. Those effects appeared at 100 to 200 mg per kg of body weight, injected into the abdomen. For an adult person, that is a vastly larger amount than anyone inhales from flower, and injection bypasses the lungs and gut. The same study found myrcene did not reduce anxiety; at higher doses it had a slight anxiety-raising effect.
Mouse results at those doses are a reason for further study. They are not evidence that the myrcene in a gram of cannabis will make a person sleepy.
Does Myrcene Change THC’s Effects?
Two independent lab teams tested this directly. A 2019 study in Cannabis and Cannabinoid Research found that beta-myrcene, along with five other common terpenes, did not activate human CB1 or CB2 receptors and did not change how THC signaled through them. A 2020 study in Frontiers in Pharmacology reached the same conclusion. If myrcene influences the cannabis experience, it is not by acting on THC’s main receptors.
The “Over 0.5% Myrcene Means Indica” Rule
A widely shared rule of thumb says cannabis with more than 0.5% myrcene will feel “indica-like.” We could not find a peer-reviewed study that establishes this cutoff. Separately, a 2021 genetic study in Nature Plants found that indica and sativa labels themselves are not reliable markers of a plant’s genetics. See our indica vs. sativa myth explainer.
The Mango Myth
Mangoes contain myrcene, and a popular tip says eating one before cannabis strengthens the high. We found no published controlled human study testing this. The amount of myrcene in a piece of fruit and how much reaches the brain are also unknown in this context. File it under folklore until someone tests it.
A Note on Safety
In 2010 the U.S. National Toxicology Program published long-term studies in which rats and mice were given large daily oral doses of beta-myrcene. Based mainly on those rodent findings, the International Agency for Research on Cancer classified beta-myrcene in 2019 as “possibly carcinogenic to humans” (Group 2B). That is the same category IARC uses for many substances where evidence comes mainly from animals. It is about high-dose, long-term exposure in rodents and does not establish risk from the amounts found in cannabis or food. It is still worth knowing if you see concentrated “added myrcene” products.
What This Means for You
- Myrcene is a real and often dominant cannabis aroma compound. It is fine to choose products for that earthy, herbal smell.
- Don’t count on myrcene to make a product sleepy. THC dose, timing and tolerance matter more; see our cannabis and sleep research review.
- If you need help sleeping, talk with a clinician, especially if you take other sedating medicines.
Clear answers
Frequently Asked Questions
Does Myrcene Make You Sleepy?
There is no controlled human evidence that the myrcene in cannabis causes sleepiness. Sedation has been shown in mice given large injected doses of 100 to 200 mg per kg of body weight.
Does Eating Mango Make Cannabis Stronger?
We found no published controlled human study supporting the mango claim. It remains folklore.
Is Myrcene Safe?
Myrcene is a common food and fragrance compound. In 2019 IARC classified beta-myrcene as possibly carcinogenic to humans (Group 2B), based mainly on high-dose, long-term rodent studies. That does not establish risk from the amounts in cannabis or food.
Does Myrcene Act on Cannabinoid Receptors?
Lab studies published in 2019 and 2020 found that beta-myrcene did not activate CB1 or CB2 receptors or change THC’s activity at them.
Sources
- do Vale TG et al., “Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba,” Phytomedicine, 2002
- Santiago M et al., “Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors,” Cannabis and Cannabinoid Research, 2019
- Finlay DB et al., “Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors,” Frontiers in Pharmacology, 2020
- Watts S et al., “Cannabis labelling is associated with genetic variation in terpene synthase genes,” Nature Plants, 2021
- National Toxicology Program, Technical Report 557: toxicology and carcinogenesis studies of β-myrcene in rats and mice (gavage studies), 2010
- IARC Monographs Volume 119, “Some Chemicals That Cause Tumours of the Urinary Tract in Rodents,” 2019 (includes β-myrcene)
- Elder HJ et al., “A Critical Review of the Interactions Between Δ9-THC and Other Naturally Occurring Phytochemical Constituents of Cannabis sativa,” Current Neuropharmacology, 2026 (online ahead of print)